MRC1 and peritonitis: For example, there is a trend of increased proportion of CD16‒CD206‒ MØ subtype in gram-negative peritonitis and failed peritonitis treatment, whereas increased proportion of CD16+CD206‒ MØ subtype in “new-starter” patients with catheter failure and stable patients with history of repeated peritonitis.